About Chipcare
Chipcare is a company based in Toronto (Canada) founded in 2009. It operates as a B2B. Chipcare has raised $11.1 million across 3 funding rounds from investors including University of Toronto, Canadian Space Agency and Grand Challenges Canada. Chipcare operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.1 M (USD)
in 3 rounds
-
Latest Funding Round
$2.8 M (USD), Series B
Nov 17, 2016
-
Investors
University of Toronto
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chipcare
Chipcare has successfully raised a total of $11.1M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $2.8 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Chipcare
Chipcare has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Toronto, Canadian Space Agency and Grand Challenges Canada.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage health science technologies are developed into business ventures by TIAP.
|
Locked | Locked | Locked | |
|
Angel investment network based in Toronto supporting Canadian startups.
|
Locked | Locked | Locked | |
|
Biotech Alliances is engaged in life science strategic advisory.
|
Locked | Locked | Locked |
Investor details for Chipcare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chipcare
Investment portfolio details for Chipcare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chipcare
Detailed financials for Chipcare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chipcare Comparisons
Peer comparison for Chipcare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chipcare
Chipcare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| Locked | Locked | Locked |
Proprietary immunoassay platform is utilized for infectious disease diagnostics.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
Detailed competitors of Chipcare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chipcare
Complete news archive for Chipcare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chipcare
Chipcare was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Chipcare is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Chipcare is a funded company, having raised a total of $11.1M across 3 funding rounds to date.
Chipcare, backed by 11095000.0 from Biotech Alliances International, TIAP, Maple Leaf Angels, Epic Capital Wealth Management, University of Toronto, Grand Challenges Canada, Canadian Space Agency, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and blood testing. Develops a hand-held blood test device from a single drop of blood. Driving innovation, growth, and excellence in its industry sectors.
Chipcare's top competitors include Souzhou Ribo Life Science, Chembio and Quantalife.
Chipcare has 7 investors. Key investors include University of Toronto, Canadian Space Agency, Grand Challenges Canada, Biotech Alliances, and TIAP.